EGFR and neoplasm: Similarly, the epidermal growth factor receptor (EGFR), and both their EGF and transforming growth factor-alpha (TGFα) ligands, as well as some members of the insulin-like growth factor (IGF) system (e.g. IGF2) [59], have all been associated with meningioma cell proliferation and tumor progression.